San Diego’s Dexcom began sales this week of Stelo, the industry’s first FDA-approved continuous glucose monitor that doesn’t require a prescription. With a two-pack of the biosensor costing just under ...
Designed to provide real-time glucose readings for an industry-leading 15.5 days, Dexcom G7 15 Day will be available in the U.S. for people over the age of 18 with diabetes beginning on Dec. 1, 2025.
The US Food and Drug Administration on Tuesday cleared the first over-the-counter continuous glucose monitoring system (CGM) in the US — the Dexcom Stelo Glucose Biosensor System — expanding glucose ...
The US Food and Drug Administration has cleared the Dexcom G7 15-Day Continuous Glucose Monitor (CGM) for people older than 18 with diabetes. It’s the longest-lasting wearable on the market. The G7 15 ...
Dexcom has announced a new continuous glucose monitoring system designed for people using basal insulin, oral therapies or GLP-1 receptor agonists1. The new system will be available shortly.
AMSL Diabetes has issued an urgent Product Correction for the Dexcom G7 iOS App version 2.12 following non-critical alerts ...
Join the event trusted by enterprise leaders for nearly two decades. VB Transform brings together the people building real enterprise AI strategy. Learn more About one in three Americans, or 125 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results